StockData
Sinovac Biotech Ltd logo

Sinovac Biotech Ltd (SVA) stock

SVANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Jun 5, 2026Score 7/30
$6.47+0.00 (0.00%)

Close on Nov 18, 2026Market cap $464.94MP/E –Yield 850.08%

Sinovac Biotech total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Sinovac Biotech's total debt was $3.32M at Dec 31, 2018. For fiscal 2018 it was $3.32M, down 81.7% from the year before. The highest annual figure on record is $47.38M in fiscal 2014.

Annual total debt

PeriodPeriod endValueChange
FY2018Dec 31, 2018$3.32M-81.7%
FY2017Dec 31, 2017$18.15M-42.0%
FY2016Dec 31, 2016$31.28M+43.6%
FY2015Dec 31, 2015$21.78M-54.0%
FY2014Dec 31, 2014$47.38M+192.1%
FY2013Dec 31, 2013$16.22M+387.1%
FY2012Dec 31, 2012$3.33M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2018Dec 31, 2018$3.32M-93.0%
Q4 FY2017Dec 31, 2017$18.15M+11.9%
Q4 FY2016Dec 31, 2016$31.28M+839.6%
Q4 FY2015Dec 31, 2015$21.78M–
Q4 FY2014Dec 31, 2014$47.38M–
Q4 FY2013Dec 31, 2013$16.22M–
Q4 FY2012Dec 31, 2012$3.33M–

More Sinovac Biotech figures

See a number that looks wrong?